Free Trial

Coya Therapeutics (COYA) Competitors

Coya Therapeutics logo
$6.67 -0.05 (-0.74%)
Closing price 04:00 PM Eastern
Extended Trading
$6.68 +0.00 (+0.07%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COYA vs. CYRX, HUMA, ATXS, PRTA, RCKT, FHTX, GLUE, AURA, ALT, and ABEO

Should you be buying Coya Therapeutics stock or one of its competitors? The main competitors of Coya Therapeutics include CryoPort (CYRX), Humacyte (HUMA), Astria Therapeutics (ATXS), Prothena (PRTA), Rocket Pharmaceuticals (RCKT), Foghorn Therapeutics (FHTX), Monte Rosa Therapeutics (GLUE), Aura Biosciences (AURA), Altimmune (ALT), and Abeona Therapeutics (ABEO). These companies are all part of the "pharmaceutical products" industry.

Coya Therapeutics vs. Its Competitors

CryoPort (NASDAQ:CYRX) and Coya Therapeutics (NASDAQ:COYA) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

In the previous week, CryoPort had 12 more articles in the media than Coya Therapeutics. MarketBeat recorded 17 mentions for CryoPort and 5 mentions for Coya Therapeutics. CryoPort's average media sentiment score of 0.89 beat Coya Therapeutics' score of 0.38 indicating that CryoPort is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CryoPort
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Coya Therapeutics
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CryoPort currently has a consensus price target of $11.11, suggesting a potential upside of 41.54%. Coya Therapeutics has a consensus price target of $16.50, suggesting a potential upside of 147.38%. Given Coya Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Coya Therapeutics is more favorable than CryoPort.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CryoPort
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Coya Therapeutics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

92.9% of CryoPort shares are held by institutional investors. Comparatively, 39.8% of Coya Therapeutics shares are held by institutional investors. 10.0% of CryoPort shares are held by company insiders. Comparatively, 12.0% of Coya Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CryoPort has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500.

Coya Therapeutics has a net margin of 0.00% compared to CryoPort's net margin of -50.15%. CryoPort's return on equity of -11.03% beat Coya Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
CryoPort-50.15% -11.03% -5.54%
Coya Therapeutics N/A -48.88%-43.32%

Coya Therapeutics has lower revenue, but higher earnings than CryoPort. Coya Therapeutics is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CryoPort$228.38M1.72-$114.76M-$2.34-3.35
Coya Therapeutics$3.55M31.43-$14.88M-$1.07-6.23

Summary

CryoPort beats Coya Therapeutics on 8 of the 15 factors compared between the two stocks.

Get Coya Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COYA vs. The Competition

MetricCoya TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$112.39M$3.03B$5.74B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E RatioN/A21.1828.1120.03
Price / Sales31.43339.44461.57200.15
Price / CashN/A43.2336.5559.01
Price / Book2.818.368.655.90
Net Income-$14.88M-$55.19M$3.25B$258.66M
7 Day Performance14.80%5.89%4.20%2.23%
1 Month Performance12.67%17.63%10.82%12.76%
1 Year Performance-9.38%5.09%34.70%19.36%

Coya Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COYA
Coya Therapeutics
1.9065 of 5 stars
$6.67
-0.7%
$16.50
+147.4%
-5.2%$112.39M$3.55M0.006News Coverage
Analyst Forecast
CYRX
CryoPort
1.7838 of 5 stars
$7.48
+11.4%
$11.11
+48.6%
-7.0%$373.54M$228.38M-3.181,186
HUMA
Humacyte
1.6564 of 5 stars
$2.31
+0.2%
$11.71
+408.2%
-66.9%$357.55M$1.57M-3.34150News Coverage
Analyst Forecast
ATXS
Astria Therapeutics
1.9456 of 5 stars
$6.28
+0.2%
$30.00
+378.1%
-42.8%$353.56MN/A-3.3530Positive News
PRTA
Prothena
3.8424 of 5 stars
$6.52
+3.6%
$31.50
+383.5%
-72.0%$351.30M$135.16M-3.14130Positive News
RCKT
Rocket Pharmaceuticals
4.8449 of 5 stars
$3.28
+4.6%
$18.60
+467.9%
-87.2%$349.72MN/A-1.25240Trending News
Analyst Forecast
Gap Down
FHTX
Foghorn Therapeutics
2.2035 of 5 stars
$6.25
+2.5%
$12.13
+94.0%
-1.0%$347.65M$22.60M-4.59120News Coverage
Positive News
GLUE
Monte Rosa Therapeutics
2.0209 of 5 stars
$5.64
-3.3%
$15.33
+172.1%
+29.8%$346.61M$75.62M70.4590
AURA
Aura Biosciences
2.4319 of 5 stars
$6.82
+0.7%
$22.00
+222.8%
-23.8%$342.59MN/A-3.5950News Coverage
Positive News
ALT
Altimmune
2.0849 of 5 stars
$4.21
+3.8%
$18.20
+332.8%
-34.4%$341.07M$20K-3.3450
ABEO
Abeona Therapeutics
3.7464 of 5 stars
$6.57
-2.7%
$19.25
+193.2%
+31.7%$336.87MN/A-5.1990

Related Companies and Tools


This page (NASDAQ:COYA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners